HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3- (2- (pyrrolidin- 1- yl)ethoxy)- 1,10b- dihydro- (1,2,4)triazolo(1,5- c)quinazolin- 5(6H)- one

putative antineoplastic agent that activates p53-mediated transcriptional activity

Also Known As:

KCG 165; KCG-165; KCG165

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Triazoles: 1533
      - 3-(2-(pyrrolidin-1-yl)ethoxy)-1,10b-dihydro-(1,2,4)triazolo(1,5-c)quinazolin-5(6H)-one: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinazolines: 402
      - Quinazolinones: 124
        3-(2-(pyrrolidin-1-yl)ethoxy)-1,10b-dihydro-(1,2,4)triazolo(1,5-c)quinazolin-5(6H)-one: 1

Experts

1.	Ha, Jae Du: 1 article (07/2007)
2.	Kim, Bum Tae: 1 article (07/2007)
3.	Lee, Woo Ghil: 1 article (07/2007)
4.	Min, Yong Ki: 1 article (07/2007)
5.	Park, Sang Eun: 1 article (07/2007)

Related Diseases

1.	Neoplasms (Cancer) 07/06/2007 - "Notably, KCG165-induced p53-dependent apoptosis in cancer cells. "